Advertisement

Topics

Mesothelioma Applied Research Foundation Company Profile

17:09 EDT 22nd June 2018 | BioPortfolio


News Articles [1006 Associated News Articles listed on BioPortfolio]

J&J To Appeal $37M Mesothelioma Verdict, A First In Talc Trials

The mesothelioma liability case marks the first in New Jersey, the first involving a male plaintiff and the first to...    

Mouse Xenograft Model for Mesothelioma

The National Cancer Institute is seeking parties interested in collaborative research to co-develop, evaluate, or commercialize a new mouse model for monoclonal antibodies and immunoconjugates that ta...

Mesothelioma Successfully Curbed in Test Animals

NewsAn international team of researchers has succeeded in stopping the growth of mesothelioma in model animals by inhibiting the heparanase enzyme.

PIM status for Boehringer’s mesothelioma drug

Boehringer Ingelheim’s nintedanib has been designated a Promising Innovative Medicine for the treatment of malignant pleural mesothelioma (MPM) by the UK Medicine and Healthcare Products Regulat...

Anticancer drug nintedanib found to be effective against malignant pleural mesothelioma

Researchers have found that nintedanib shows promising effectiveness in halting the growth of human malignant pleural mesothelioma in preclinical models. The post Anticancer drug nintedanib found to ...

Blavatnik Family Foundation provides $10 million to promote engineering innovations in health

(Columbia University School of Engineering and Applied Science) Columbia Engineering announces a $10 million grant from the Blavatnik Family Foundation to fund innovative research at the intersection ...

A novel research partnership in AI to advance drug discovery, longevity and aging research

(Biogerontology Research Foundation) Biogerontology Research Foundation CSO to collaborate with Insilico Medicine and WuXi AppTec on a research study in artificial intelligence for drug discovery. The...

Talcum Powder Lawsuit Trial Concludes, Jury Awards $37M To Mesothelioma Plaintiff

NewsJohnson & Johnson and Imery's Talc America have been ordered to pay $37 million to a New Jersey man who was diagnosed with mesothelioma following years of talcum powder use.

PubMed Articles [1665 Associated PubMed Articles listed on BioPortfolio]

Personalized chemosensitivity assays for mesothelioma- is it worth the effort?

Cell-lines formed from an individual's tumor can be used to predict response to specific therapies and determine genomic predictors. For mesothelioma, where chemotherapy remains the backbone of curren...

Mesothelioma occurrence in taconite miners; assessing the role of non-asbestiform EMP.

The purpose of this paper was to assess the role of non-asbestiform amphibole EMPs in the etiology of mesotheliomas in taconite (iron ore) miners. Increased mesothelioma rates have been described in M...

Revised Modified RECIST Criteria for Assessment of Response in Malignant Pleural Mesothelioma (Version 1.1).

Malignant pleural mesothelioma poses unique difficulties in tumor measurement and response assessment; however, robust and reproducible assessment of response is critically important in the conduct, i...

Non-Coding Transcript Heterogeneity in Mesothelioma: Insights from Asbestos-Exposed Mice.

Mesothelioma is an aggressive, rapidly fatal cancer and a better understanding of its molecular heterogeneity may help with making more efficient therapeutic strategies. Non-coding RNAs represent a la...

Validation of the diagnosis of mesothelioma and BAP1 protein expression in a cohort of asbestos textile workers from Northern Italy.

Diagnosis of mesothelioma based on death certificate is subject to misclassification, which may bias the results of epidemiology studies. A high proportion of mesothelioma harbor mutations in the BRCA...

Clinical Trials [2796 Associated Clinical Trials listed on BioPortfolio]

Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia

RATIONALE: Studying levels of mesothelin and osteopontin in samples of blood from patients with mesothelioma or atypical mesothelial hyperplasia may help doctors identify biomarkers relate...

Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity

For patients with malignant pleural mesothelioma that has grown despite treatment with standard chemotherapy, no treatment has yet proven beneficial. The purpose of this study is to find o...

SU5416 in Treating Patients With Malignant Mesothelioma

RATIONALE: SU5416 may stop the growth of malignant mesothelioma by stopping blood flow to the tumor. PURPOSE: Phase II trial to study the effectiveness of SU5416 in treating patients who ...

A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma

This research study is studying a pair of immunotherapies as a possible treatment for malignant pleural mesothelioma. The drugs involved in this study are: - Durvalumab ...

A Study Comparing Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Alone in the Treatment of Mesothelioma

Based on results from earlier clinical trials, Pemetrexed may have antitumor activity as a first-line agent in the treatment of mesothelioma. Given this, it is hypothesized that Pemetrexed...

Companies [2839 Associated Companies listed on BioPortfolio]

The Mesothelioma Applied Research Foundation

The Meso Foundation is the only 501(c)(3) nonprofit organization dedicated to eradicating mesothelioma and easing the suffering caused by this cancer. The Meso Foundation actively...

Mesothelioma Applied Research Foundation

Baron & Budd, P.C. .

The national mesothelioma law firm of Baron & Budd, P.C. has a more than 30-year history of “Protecting What’s Right” for asbestos sufferers and their families. As ...

Simmons Firm

The Simmons Firm, headquartered in Alton, Ill., is one of the country’s leading asbestos and mesothelioma litigation firms. With offices in Illinois, Missouri and California,...

Simmons Browder Gianaris Angelides & Barnerd LLC

The Simmons Firm, headquartered in Alton, Ill., is one of the country’s leading asbestos and mesothelioma litigation firms. With offices in Illinois, Missouri and California,...

More Information about "Mesothelioma Applied Research Foundation" on BioPortfolio

We have published hundreds of Mesothelioma Applied Research Foundation news stories on BioPortfolio along with dozens of Mesothelioma Applied Research Foundation Clinical Trials and PubMed Articles about Mesothelioma Applied Research Foundation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Mesothelioma Applied Research Foundation Companies in our database. You can also find out about relevant Mesothelioma Applied Research Foundation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record